NSE vs BSE: Should Investors Buy BSE Shares Now or Wait for the IPO?

The National Stock Exchange (NSE) has finally filed its Draft Red Herring Prospectus (DRHP) with SEBI, bringing India’s most anticipated stock market listing closer to reality after a decade of delays. This milestone has triggered intense debate among investors: should they accumulate BSE shares now, or wait to participate in the NSE IPO?

The NSE Filing: A Confirmation Rather Than a Trigger

For much of the last year, the market has been speculating about the NSE listing. Analysts suggest that the DRHP filing acts more as a confirmation event than a fresh catalyst for stock prices. Because the market had already begun pricing in the possibility of the NSE listing, the news essentially removes the "will it happen" uncertainty rather than introducing new value.

Crucially, the NSE IPO is structured as a pure offer-for-sale (OFS). This means no fresh capital will enter the NSE; instead, existing shareholders will simply transfer their stakes. Furthermore, in a unique twist for the Indian markets, the NSE shares are slated to list on the BSE itself.

BSE’s Valuation: Sentiment vs. Substance

Investors are currently grappling with whether BSE's recent stock rally is driven by genuine business fundamentals or mere excitement surrounding its rival. Paresh Bhagat, Chairman of Mangal Keshav Financial, notes that while reassessing BSE due to the NSE news is a "natural knee-jerk reaction," the structural core of BSE’s business remains unchanged.

The stock has already seen a significant run-up, driven by:

  • Expansion in its derivatives market share.
  • Robust earnings growth and operating leverage.
  • Increased retail participation and mutual fund inflows in India.

Sourav Choudhary, MD at Raghunath Capital, suggests that much of the positive sentiment regarding the NSE listing is already reflected in BSE's current price. He argues that the next leg of growth for BSE will depend on its ability to deliver earnings through volume growth and new product approvals, rather than event-driven optimism.

The Benchmarking Effect: A Double-Edged Sword

While the NSE listing might not immediately re-rate BSE, it will provide a critical valuation benchmark. Ishan Tanna, Senior Associate at Ashika Capital, highlights that the NSE filing gives investors a direct way to compare the two exchanges on metrics like profitability and growth prospects.

This creates a period of heightened "valuation discipline." Once NSE is priced, investors will closely scrutinize BSE's relative value. If NSE lists at a premium, it could validate the entire capital market infrastructure sector; however, if its valuation is conservative, BSE may face pressure to justify its own multiples.

Strategic Outlook for Investors

The decision to invest should not be a binary choice between waiting for the NSE IPO or buying BSE. Since the NSE listing is still months away (with potential timelines stretching into 2026), investors must decide if BSE's current price aligns with their long-term view of India's financialization.

Key Takeaways

  • Market Pricing: Much of the NSE listing anticipation is already factored into BSE's stock price, meaning the DRHP filing is a confirmation rather than a new price driver.
  • Earnings over Events: Future upside for BSE is more likely to be driven by its own derivatives franchise and profit growth rather than the NSE IPO timeline.
  • Valuation Comparison: The NSE listing will provide a definitive benchmark, forcing investors to compare the two exchanges based on actual growth and profitability metrics.